nasal vaccine BBV154 Current Affairs, GK & News

Nasal Covid Vaccine Gets Regulatory Nod for further trials

India’s first nasal vaccine against COVID-19 has received the nod to conduct phase 2 and 3 clinical trials by the Department of Biotechnology. Key Points Nasal Covid Vaccine has been developed by Bharat Biotech. Vaccine has successfully completed Phase 1 clinical trial in age groups of 18 to 60 years. According to the officials, doses ..

Month: 

Category: 

Topics: